University of Dundee

Drug Discovery Unit

Short Code: 
DDU

DMPK Project Lead

The Drug Discovery Unit (DDU) (see http://www.drugdiscovery.dundee.ac.uk) is a fully integrated drug discovery operation based within a world-class Life Sciences research environment. Our remit is to complement BioPharma activities by tackling both neglected disease drug discovery (leishmaniasis, Chagas disease, TB, Cryptosporidiosis and malaria) and validating novel drug targets across a range of therapeutics areas.

Team Leader – Molecular Interactions Team (structural biology, biophysics and protein expression)

We are seeking an innovative and motivated scientist to lead a team of around 12 scientists providing structural biology, biophysics and protein expression expertise into structurally enabled drug discovery projects within the Drug Discovery Unit, University of Dundee (www.drugdiscovery.dundee.ac.uk/).

Dundee scientist is Scotland’s top entrepreneurial academic

Dr Andrew Woodland has been named the winner of the 2019 Converge Challenge, scooping £78,000 to develop his new drug discovery company, In4Derm.

At a glittering reception at V&A Dundee, Dr Woodland triumphed over 17 fellow academic entrepreneurs with his business, which re-engineers oral drugs and turns them into novel topical drugs to improve the lives of patients living with skin diseases such as eczema.

DMPK Project Lead

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

DMPK Project Lead

The School of Life Sciences at the University of Dundee is a world-class academic institution with a reputation for the excellence of its research, its high quality teaching and student experience, and the strong impact of its activities outside academia. With 900 staff from over 60 countries worldwide the School provides a dynamic, multi-national, collegiate and diverse environment with state-of-the-art laboratory, technology and teaching facilities.

MMV Project of the Year Award for Dundee researchers

Researchers from the Drug Discovery Unit have been awarded the “Project of the Year 2018” from Medicines for Malaria Venture (MMV) for their discovery work on potential new drugs for malaria.

The annual award goes to the scientific partners involved in that year’s most exciting project from the MMV portfolio. MMV is the world’s leading product development partnership (PDP) for discovering and developing new effective and affordable medicines to treat malaria.

DDU partners with Bukwang Pharmaceutical Company to tackle new drug treatment for Parkinson’s disease

The Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease. This announcement builds upon existing drug discovery partnerships the DDU has with Takeda and GSK.

Parkinson’s disease is the second most common neurological disorder, after Alzheimer’s disease, affecting around two people in every 1000 across the population. There are around 6.1 million people worldwide and 120,000 people in the UK living with the condition.

Pages